Cheng Chen

Hangzhou Normal University

H指数:23

被引数:1,470

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Advanced oral therapies for colorectal cancer via nanomedicine and microbiota modulation

通过纳米医学和微生物组调控的结直肠癌先进口服疗法

Advanced Drug Delivery Reviews

IF17.6

2025-11-220

PRE

An antioxidant metal-organic framework with functional coatings for oral anti-TNF-α antibody delivery in inflammatory bowel disease treatment

一种具有功能涂层的抗氧化金属有机框架，用于炎症性肠病治疗中的口服抗TNF-α抗体递送

Journal of Controlled Release

IF11.5

2025-11-140

OAAI

A novel β-carboline alkaloid derivative targeting MDM2-p53 pathway suppresses colorectal cancer progression

一种靶向MDM2-p53通路的新型β-咔啉生物碱衍生物可抑制结直肠癌进展

Cellular Oncology

IF4.8

2025-10-060

Mechanisms of Allicin Improving Immunotherapy in Non-Small Cell Lung Cancer by Modulating KDM5B/SETDB1 Axis

大蒜素通过调控KDM5B/SETDB1轴改善非小细胞肺癌免疫治疗的机制

DISCOVERY MEDICINE

IF2.1

2025-10-010

OAAI

Polymeric micellar paclitaxel, cisplatin, and tislelizumab as first-line therapy for advanced unresectable esophageal squamous cell carcinoma: a phase II study with resistance profiling in poor responders

聚合物胶束紫杉醇、顺铂和tiselizumab作为晚期不可切除食管鳞状细胞癌的一线疗法：一项包含对低应答者进行耐药性分析的II期研究

Drug Resistance Updates

IF21.7

2025-09-080

PRE

Bird-Inspired Time-Domain Analysis: High-Robustness Intelligent Sensing of Hypochlorite Aerosols

鸟类启发的时域分析：次氯酸气溶胶的高鲁棒性智能传感

Environmental Science & Technology

IF11.3

2025-07-310

PRE

LIFU-unlocked endogenous H2S generation for enhancing atherosclerosis-specific gas-enzymatic therapy

BIOMATERIALS

IF12.9

2025-04-010

PRE

Oral Lipid-Based Nanomedicine for the Inhibition of the cGAS-STING Pathway in Inflammatory Bowel Disease Treatment

基于脂质的口服纳米药物在炎症性肠病治疗中对cGAS-STING通路的抑制作用

MOLECULAR PHARMACEUTICS

IF4.5

2025-03-030

PRE

IRX5's influence on macrophage polarization and outcome in papillary thyroid cancer

FRONTIERS IN ONCOLOGY

IF3.3

2024-05-292

OAAI

Green synthesized versus chemically synthesized zinc oxide nanoparticles: In vivo antihyperglycemic activity and pharmacokinetics

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2024-01-014

PRE

Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease

ADVANCED DRUG DELIVERY REVIEWS

IF17.6

2023-12-019

PRE

Mechanical and degradative properties of PLDLA biodegradable pins with bioactive glass fibers in a beagle model (vol 15, 035010, 2022)

BIOMEDICAL MATERIALS

IF3.7

2023-11-200

Enhance Mitochondrial Damage by Nuclear Export Inhibition to Suppress Tumor Growth and Metastasis with Increased Antitumor Properties of Macrophages

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2023-04-206

PRE

Genetically predicted alterations in thyroid function are associated with the risk of benign prostatic disease

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-04-175

OAAI

NIR Activated Multimodal Therapeutics Based on Metal-Phenolic Networks-Functionalized Nanoplatform for Combating against Multidrug Resistance and Metastasis

SMALL

IF12.1

2023-01-1814

PRE

Biomimetic, pH-Responsive Nanoplatforms for Cancer Multimodal Imaging and Photothermal Immunotherapy

用于癌症多模式成像和光热免疫治疗的仿生，pH响应纳米平台

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2022-12-2915

PRE

Nanoenabled Tumor Energy Metabolism Disorder via Sonodynamic Therapy for Multidrug Resistance Reversal and Metastasis Inhibition

通过声动力疗法实现纳米肿瘤能量代谢紊乱，用于逆转多药耐药和抑制转移

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2022-12-2812

PRE

Peptide Supramolecular Assembly-Instructed In Situ Self-Aggregation for Stratified Targeting Sonodynamic Therapy Enhancement of AIE Luminogens

肽超分子组装指导的原位自聚集，用于分层靶向声动力学治疗增强AIE发光体

ADVANCED SCIENCE

IF14.1

2022-12-0916

Performance of the IOTA ADNEX model combined with HE4 for identifying early-stage ovarian cancer

IOTA ADNEX模型联合HE4鉴定早期卵巢癌的性能

FRONTIERS IN ONCOLOGY

IF3.3

2022-09-166

OAAI

Efficient Photoinduced Thermocatalytic Chemiluminescence System Based on the Z-Scheme Heterojunction Ag3PO4/Ag/Bi4Ti3O12 for H2S Sensing

ANALYTICAL CHEMISTRY

IF6.7

2022-06-2113

PRE

Cheng Chen

个人简介

教育背景

工作经历

荣誉奖项

研究方向